DEXCEL-PHARMA LIMITEDActive
Key figures
Ratios
2025Balance sheet structure
Filed accounts2020–2025
| 2020 | 2022/23 | 2023/24 | 2025 | |
|---|---|---|---|---|
| Turnover | 14,650,829 | 27,584,426 | 21,547,541 | 39,086,522 |
| Profit for the year | 446,756 | 2,331,070 | 1,470,991 | 3,653,030 |
| Cash at bank and in hand | 841,337 | 3,196,746 | 2,393,049 | 4,306,826 |
| Total assets | 16,249,054 | 20,607,374 | 34,907,262 | 35,610,533 |
| Total liabilities | 5,256,845 | 6,446,446 | 12,913,043 | 9,965,900 |
| Net assets / total equity | 10,992,209 | 14,160,928 | 21,880,858 | 25,533,888 |
| Average number of employees | 20 | 21 | 22 | 25 |
| Average pay (per year) | 60,564 | 100,545 | 74,889 | 120,933 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The principal activity of the Company is to market, sell and distribute generic medicines to wholesalers, pharmacies and healthcare providers, over the counter (OTC) medications to major grocery retailers and pharmacies, as well as patented speciality products to dental healthcare professionals.
As described in the company's latest filed accounts.
Summary: DEXCEL-PHARMA LIMITED
Company
DEXCEL-PHARMA LIMITED is a private limited company registered with Companies House under company number 02963398. It was incorporated on 31 Aug 1994. Its status is active. The registered office is in Coventry (CV1). Its nature of business (SIC 2007) is wholesale of pharmaceutical goods (46460).
Accounts
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files full accounts. Turnover was £39,086,522. Profit for the year was £3,653,030. Net assets were £25,533,888, up 16.7% on the previous year. Cash at bank and in hand was £4,306,826. Total assets were £35,610,533 and total liabilities £9,965,900. The company had an average of 25 employees. Figures are available for 4 financial years (2020–2025).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 6 Sep 2027.